|
Home : Unsafe Drugs : Avandia : Newsfeeds : FDA advisory panel decision on Avandia looms FDA advisory panel decision on Avandia looms
Depending on the outcome, marketing authorization for the drug in Europe could be revoked or changed. Avandia (rosiglitazone) is one of two blood-sugar-lowering drugs in the class of medications known as thiazolidinediones (TZDs). The other drug is Actos ...
Avandia Case Evaluation Form
This form is secure and encrypted. More information about secure forms and your privacy here.
|




